Palisade Bio Q2 EPS $(0.05), Inline, Sales $500.000K
Benzinga Newsdesk 2 months ago
NewsEarnings
Palisade Bio (NASDAQ:PALI) reported quarterly losses of $(0.05) per share which met the analyst consensus estimate. This is a 91.38 percent increase over losses of $(0.58) per share from the same period last year. The
Palisade Bio (NASDAQ:PALI) reported quarterly losses of $(0.05) per share which met the analyst consensus estimate. This is a 91.38 percent increase over losses of $(0.58) per share from the same period last year. The company reported $500.000 thousand in sales this quarter.